Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1056 of 5804
-
New online program aims to ease trauma in young cancer survivors
Symptom relief Not yet recruitingThe goal of this study is to develop a virtual group intervention to address post-traumatic stress related to cancer in young adult cancer survivors (YACs, aged 18-39). The study team will do this by integrating evidence-guided treatments and expert clinician feedback (N=10) on t…
Phase: NA • Sponsor: Zeba Ahmad, Ph.D. • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Can a magnetic helmet lift depression? new study investigates
Symptom relief Recruiting nowThe orbitofrontal cortex (OFC), a region involved in emotional regulation, decision making, and reward processing, is a key area linked to antidepressant response. This study tests whether noninvasive stimulation of the OFC using transcranial magnetic stimulation (TMS) can improv…
Phase: NA • Sponsor: Subha Subramanian • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New drug combo aims to tame stubborn psoriatic arthritis
Disease control Not yet recruitingThe purpose of this research study is to determine the effectiveness of adding deucravacitinib to the participant's current Psoriatic Arthritis (PsA) treatment to see if it improves their symptoms and quality of life. This study is exploring a new treatment approach that may hel…
Phase: PHASE4 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Shock therapy at home? new trial tests brain zaps for speech loss
Symptom relief Recruiting nowThe goal of this clinical trial is to learn whether home-based brain stimulation combined with virtual speech-language therapy can improve communication abilities in adults with logopenic variant primary progressive aphasia (lvPPA), a language disorder most often caused by Alzhei…
Phase: NA • Sponsor: Maya Henry • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New drug aims to reverse bone marrow scarring in rare blood cancer
Disease control Recruiting nowWe hypothesize that pacritinib leads to modification of the myelofibrosis (MF) disease phenotype, especially related to BM fibrosis and cytopenias; due potentially to its dual effect as an inhibitor of the JAK and NFκB pathways, through its targets JAK2 and IRAK1 respectively, le…
Phase: PHASE2 • Sponsor: Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a gentle brain zap boost stroke arm recovery?
Symptom relief Not yet recruitingThe objective of this clinical trial is to evaluate the effects of transcranial direct current stimulation (tDCS) combined with constraint-induced therapy (CIT) on upper limb motor recovery in individuals after stroke. The main questions it aims to answer are: Does the combinat…
Phase: NA • Sponsor: Universidade do Estado do Pará • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New combo pill aims to end recurring vaginal infections
Prevention Not yet recruitingThis trial employed a multicenter, randomized, double-blind, parallel, placebo-controlled design to evaluate the preventive effect of BPR-101 capsules combined with metronidazole on the recurrence of BV, as well as the cure rate and safety.
Phase: PHASE2 • Sponsor: Chengdu Syncor Pharmaceutical Co., Ltd. • Aim: Prevention
Last updated Jun 27, 2026 11:02 UTC
-
Can a zap to the neck help smokers quit? new trial tests nerve stimulator
Disease control Recruiting nowThe purpose of this study is to provide preliminary evidence for the efficacy of 12 weeks of vagal nerve stimulation (VNS) and nicotine replacement therapy (NRT) for increasing smoking abstinence rates.
Phase: PHASE2, PHASE3 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New implant study tracks Real-World results for rheumatoid arthritis patients
Disease control Not yet recruitingProspective, multicenter, post-market, registry study designed to systematically collect real-world data (RWD) from participants implanted with the SetPoint System \[implanted, vagus-mediated, neuroimmune modulator\] for the treatment of adults with moderately to severely active …
Sponsor: SetPoint Medical Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New injection aims to control tough blood cancers in early trial
Disease control Not yet recruiting(Limit: 5000 characters) The purpose of this phase I clinical study aims to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of SYS6055 Injection in participants with relapsed/refractory B-cell malignancies, and to provide evidence for r…
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Virtual reality boosts brain recovery in stroke patients
Symptom relief Not yet recruitingThis pilot randomized controlled trial aims to evaluate the effectiveness of cognitive rehabilitation using an immersive Virtual Reality (VR) system compared to conventional paper-and-pencil cognitive training in subacute stroke patients. A total of 22 participants will be random…
Phase: NA • Sponsor: Universitas Padjadjaran • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Bedside yoga may ease postpartum depression and strengthen Mother-Infant bond
Symptom relief Not yet recruitingPerinatal depression (PND), defined as a depressive episode occurring from the antenatal period through 12 months following childbirth, has a reported prevalence of 12-22%, with higher rates in low- and middle-income countries (LMICs) including India. PND has a multifaceted and d…
Phase: NA • Sponsor: All India Institute of Medical Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New combo therapy aims to hit MS early and hard
Disease control Not yet recruitingThe HiHat trial is a Phase 2 study aimed at evaluating the safety and feasibility of sequential treatment with rituximab and cladribine in patients with relapsing-remitting multiple sclerosis (RRMS). The study follows a prospective, open-label, single-arm design, with 60 RRMS pat…
Phase: PHASE2 • Sponsor: Uppsala University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New hope for Crohn's patients: drug may stop disease return after surgery
Disease control Not yet recruitingThe goal of this single arm ,non-interventional, prospective, descriptive study is to evaluate the efficacy of guselkumab treatment in preventing endoscopic recurrence of Crohn's Disease in adult participants who have a documented diagnosis of moderate to severe CD and have under…
Sponsor: Shanghai 10th People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Natural compound SAMe tested to block liver cancer in High-Risk patients
Prevention Not yet recruitingThis study will evaluate the safety, feasibility, and preliminary effects of S-adenosyl-L-methionine (SAMe) compared with placebo in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) cirrhosis. Investigators will assess whether treatment is associated…
Phase: PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
New blood filter may shield heart surgery patients from organ failure
Disease control Recruiting nowThis randomized controlled study aims to evaluate the efficacy and safety of intraoperative and early postoperative hemoadsorption using the Efferon® LPS device in patients undergoing cardiac surgery with cardiopulmonary bypass in reducing the incidence and severity of multiple o…
Phase: NA • Sponsor: Efferon JSC • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could stem cells restore ovarian function? new trial begins
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the safety, tolerability and efficacy of human umbilical cord mesenchymal stem cell injection (HS\_SW01 cells injection) in patients with Primary Ovarian Insufficiency (POI). Participants will be required to sign the informed consen…
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Huishan Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Targeted PET imaging could revolutionize cancer treatment selection
Diagnosis Not yet recruitingThe purpose of this study is to use Claudin 18.2 (CLDN18.2)-targeted positron emission tomography (PET) imaging technology to evaluate its detection efficacy and diagnostic threshold for CLDN18.2-positive pancreatic cancer and gastric/gastroesophageal junction cancer, analyze the…
Sponsor: Ruijin Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
New hope for stubborn low platelets after transplant?
Disease control Not yet recruitingThis is a prospective, open-label phase 1b/2 clinical trial to explore the safety and efficacy profiles of baricitinib in patients with thrombopoietin-receptor-agonist-refractory persistent thrombocytopenia after allogeneic hematopoietic stem cell transplantation.
Phase: PHASE1, PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can a tailored web portal help pancreatic cancer patients exercise and eat better during chemotherapy?
Symptom relief Recruiting nowThis clinical trial studies whether a tailored, web-based program (web portal), Community for Physical Activity and Supportive Nutrition Strategies (COMPASS), can be used to improve exercise and dietary changes in patients with stage I-III pancreatic cancer who are receiving chem…
Phase: NA • Sponsor: OHSU Knight Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC